Blüm Holdings Inc. Annual report pursuant to Section 13 and 15(d)

Annual report pursuant to Section 13 and 15(d)

CONSOLIDATED STATEMENTS OF STOCKHOLDERS EQUITY

CONSOLIDATED STATEMENTS OF STOCKHOLDERS EQUITY - USD ($) shares in Thousands, $ in Thousands	Total	People’s California	Silverstreak	Umbrla, Inc.	Cumulative Effect, Period of Adoption, Adjustment	Series A Convertible Preferred Stock	Common Stock	Common Stock People’s California	Common Stock Silverstreak	Common Stock Umbrla, Inc.	Additional Paid-In Capital	Additional Paid-In Capital People’s California	Additional Paid-In Capital Silverstreak	Additional Paid-In Capital Umbrla, Inc.	Additional Paid-In Capital Cumulative Effect, Period of Adoption, Adjustment	Treasury Stock	Accumulated Deficit	Accumulated Deficit Cumulative Effect, Period of Adoption, Adjustment	Non- Controlling Interest
Beginning balance (in shares) at Dec. 31, 2019						8	118,004,978									2,308,412
Beginning balance at Dec. 31, 2019	$ 75,326						$ 120				$ 260,516					$ (808)	$ (189,686)		$ 5,184
Stock compensation - employee (in shares)							3,894,544
Stock compensation - employees	519						$ 4				515
Stock compensation - directors (in shares)							1,359,090
Stock compensation - directors	104						$ 1				103
Stock compensation - services expense (in shares)							1,159,615
Stock compensation - services expense	152						$ 1				151
Stock cancellation (in shares)							(21,924,177)
Debt conversion - common stock (in shares)							31,086,209
Debt conversion - common stock	2,444						$ 31				2,413
Stock issued for cash (in shares)							2,470,173
Stock issued for cash	250						$ 2				248
Stock option expense (in shares)							58,154,027
Stock option expense	9,304						$ 58				9,246
Warrants issued	1,868										1,868
Contribution (distribution) to non-controlling interest	33																		33
Net income (loss) attributable to non-controlling interest	(754)																		(754)
Net loss attributable to Unrivaled Brands, Inc.	(30,117)																(30,117)
Ending balance (in shares) at Dec. 31, 2020						8	194,204,459									2,308,412
Ending balance at Dec. 31, 2020	59,130				$ (12)		$ 218				275,060				$ (1,071)	$ (808)	(219,803)	$ 1,059	4,463
Stock compensation - employee (in shares)							250,000
Stock compensation - employees	67										67
Stock compensation - directors (in shares)							1,917,837
Stock compensation - directors	495						$ 2				493
Stock compensation - services expense (in shares)							4,556,603
Stock compensation - services expense	1,079						$ 5				1,074
Debt conversion - common stock (in shares)							24,939,780
Debt conversion - common stock	5,056						$ 25				5,031
Stock issued for cash (in shares)							9,677,419
Stock issued for cash	3,756						$ 10				3,746
Stock option exercise (in shares)							3,381,878
Stock option exercises	5						$ 3				2
Stock option expense	2,415										2,415
Warrants issued	5,978										5,978
Series A (in shares)							16,485,714									8
Series A	5,891						$ 17				5,874
Stock issued for acquisition (in shares)								40,000,000	9,051,412	191,772,781
Stock issued for acquisition (in shares)		$ 12,180	$ 2,500	$ 79,822				$ 40	$ 9	$ 192		$ 12,140	$ 2,491	$ 79,630
Net income (loss) attributable to non-controlling interest	(604)																		(604)
Net loss attributable to Unrivaled Brands, Inc.	(31,271)																(31,271)
Ending balance (in shares) at Dec. 31, 2021						8	496,237,883									2,308,420
Ending balance at Dec. 31, 2021	$ 146,487						$ 521				$ 392,930					$ (808)	$ (250,015)		$ 3,859
Accounting Standards Update [Extensible Enumeration]	Accounting Standards Update 2020-06 [Member]